December 22, 2020 -- Co-Diagnostics announced that it has developed a molecular test for mutations that have been associated with a new variant of the coronavirus that has been causing alarm.
The company said in a statement that its polymerase chain reaction (PCR) test screens for the variant under investigation (VUI) circulating in the U.K. and causing much alarm -- VUI 202012/01. The emergence of a SARS-CoV-2 strain that appears to be more easily transmitted has led to tighter lockdowns in the U.K. and global travel bans for residents.
The performance of the company's commercially available COVID-19 tests is not thought to be adversely affected by the new strain, said Co-Diagnostics, which is based in Salt Lake City.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current